|Data Element ID:||DE270|
|Name:||Type of substance involved|
|Data Element ISO Name:||Event_Medication-Substance_Type,CD|
|Synonym:||None defined at this time|
|Definition:||Determination of the type of medication/substance involved in the event.|
|Question:||What type of medication/substance was involved?|
|Conditionality:||Reserved for future use|
|Multiple Choice:||Not Applicable|
|Form Name:||Medication or Other Substance|
|Data Set:||Reserved for future use|
|Setting:||Hospitals, including outpatient pharmacies and outpatient departments located within the hospital|
|Comments:||None defined at this time|
|Description of Change:||Not applicable for this release|
|Go-To Logic:||Refer to Common Formats Flow Charts|
|Guide For Use:||
The substances whose use is covered by the Medications or Other Substances Common Formats, with the exception of expressed human breast milk, are articles or substances regulated by the Food and Drug Administration (FDA). See, Title 21, Code of Federal Regulations (CFR).
A 'medication' is a type of drug.
A 'biological product' means any virus, therapeutic serum, toxin, antitoxin, or analogous product applicable to the prevention, treatment or cure of disease or injury. 21 CFR 600.3
A 'nutritional product', for the purposes of these Common Formats, does not include "conventional" food.
'Expressed human breast milk' is human breast milk that was produced by manipulating the lactating breast, either by hand or with a breast pump.
A 'Medical gas (e.g., oxygen, nitrogen, nitrous oxide)' also includes medical air or an inhalation anesthetic and, when manufactured, packaged and intended for administration to a patient in anesthesia, therapy or diagnosis, constitutes a type of drug.
'Contrast media' constitute a type of drug. They are used to enhance the contrast of structures or fluids within the body during medical imaging.
A 'radiopharmaceutical' is a radioactive chemical or pharmaceutical preparation that is labeled with a radionuclide in tracer or therapeutic concentration and this is used as a diagnostic or therapeutic agent.
|HL7 Data Type:||Concept Descriptor (CD)|
|Answer Code||Answer ID||Answer Value||Code System||Code System Name|
|A1197||a||Medication||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1200||b||Biological product||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1203||c||Nutritional product||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1206||d||Expressed human breast milk||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1209||e||Medical gas (e.g., oxygen, nitrogen, nitrous oxide)||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1212||f||Contrast media||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1213||g||Radiopharmaceutical||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1214||h||Patient food (not suspected in drug-food interaction)||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1215||i||Other substance: Please specify||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|Until Date:||- -|
|Update Date:||- -|
|Source:||Agency for Healthcare Research and Quality|
|Submitting Organization:||Agency for Healthcare Research and Quality (AHRQ)|
|Date of Submission:||03/31/2010|
|Responsible Organization:||Agency for Healthcare Research and Quality (AHRQ)|
|Creator:||John C. Moquin|
|Data Steward:||Agency for Healthcare Research and Quality (AHRQ)|
|References:||No specific reference at this time|
|Rationale for Change:||Not Applicable|
|Administrative Status Date:||03/31/2010|